COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=52394

Shuihua Lu

lushuihua@shphc.org.cn

2020-04-29

Not recruiting

RCT

Randomized

Parallel

Not reported

unclear

Prevention

1. Healthy subjects with negative covid-19 nucleic acid test and antibody test, 2. Aged 18-70 years old, 3. Signed informed consent and participated in the study voluntarily.

1. Patients allergic to chloroquine and hydroxychloroquine, 2. Pregnant women, 3. Patients with severe diseases of heart, lung, kidney, brain, blood and other important organs and dysfunction, 4. Patients with retinopathy, hearing loss or hearing loss, 5. Patients with severe neurological and psychiatric diseases, 6. Subjects who, in the opinion of the investigator, were unable to complete the study as required or were not suitable to participate in the study.

2

Shanghai Public Health Clinical Center

18

70

China

Healthy volunteers

N/A

2000

Detection of nucleic acid and antibody of new coronavirus ;

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 4

[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]